Prophylactic Effect of Mycobacterium bovis BCG Vaccination against Osteomyelitis in Children with Mycobacterium ulcerans Disease (Buruli Ulcer)

Mycobacterium ulcerans disease, or Buruli ulcer (BU), causes significant morbidity in West Africa. In 233 consecutive, laboratory-confirmed samples from BU patients in Benin whose Mycobacterium bovis BCG scar status was known, 130 children (<15 years old) and 75 adults had a neonatal BCG vaccination...

Celý popis

Podrobná bibliografie

Vydáno v:	Clin Diagn Lab Immunol
Hlavní autoři:	Portaels, F., Aguiar, J., Debacker, M., Steunou, C., Zinsou, C., Guédénon, A., Meyers, W. M.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 2002
Témata:	Experimental Clinical Investigation
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC130119/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12414782/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/CDLI.9.6.1389-1391.2002
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!